<DOC>
	<DOCNO>NCT01427842</DOCNO>
	<brief_summary>Current Australian guideline vancomycin commonly underdoses individual particularly first 48 hour . The aim trial compare two dosing regimen ; current Australian guideline versus appropriately model pharmacokinetic base regimen overall aim develop new vancomycin dose strategy enable patient individualise therapeutically efficacious treatment . The hypothesis dose vancomycin accord pharmacokinetically model regimen increase likelihood achieve therapeutic trough level vancomycin within first 48 hour ( steady state , whichever sooner ) compare dose vancomycin accord current Antibiotic guideline .</brief_summary>
	<brief_title>Dose Enhancement Vancomycin IN Everyday Patients</brief_title>
	<detailed_description>DEVINE randomise control trial new vancomycin dose regimen control . The control group regimen receive dos recommend Therapeutic Guidelines - Antibiotics 2010 . The intervention group receive dose regimen devise model antibiotic property within body large range renal function weight specific individual patient . They receive regimen approximately 36-60 hour point vancomycin level blood test ( routine practice part normal care ) . After time treat team determine dosing requirement . All patient randomise commencement vancomycin consent obtain trial prior first dose vancomycin</detailed_description>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>All patient general ward require routine treatment vancomycin GFR &lt; 30mL/min ( measure Cockcroft Gault equation ) Age &lt; 16 yr Weight &gt; 200kg Patients dose Vancomycin BD accord national guideline ( ie continuous infusion , q6h etc ) Vancomycin infused rate 500mL/min</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Trough concentration</keyword>
	<keyword>Vancomycin</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>